pubmed-article:3760275 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:3760275 | lifeskim:mentions | umls-concept:C0040262 | lld:lifeskim |
pubmed-article:3760275 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:3760275 | lifeskim:mentions | umls-concept:C0022625 | lld:lifeskim |
pubmed-article:3760275 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:3760275 | lifeskim:mentions | umls-concept:C1696465 | lld:lifeskim |
pubmed-article:3760275 | lifeskim:mentions | umls-concept:C1378128 | lld:lifeskim |
pubmed-article:3760275 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:3760275 | pubmed:dateCreated | 1986-11-20 | lld:pubmed |
pubmed-article:3760275 | pubmed:abstractText | Malassezia furfur (Pityrosporum orbiculare) was confirmed by microscopic potassium hydroxide (KOH) examination in 101 patients with recurring lesions of tinea versicolor. In a double-blind comparative study, patients were randomly assigned to once-daily ketoconazole 2% or placebo cream. At the end of treatment, 98% (p less than 0.0001) of the patients using ketoconazole and 28% of those using placebo responded clinically (healed or had mild residual disease). There was an overall 84% mycologic cure rate (negative KOH at treatment end) for patients using ketoconazole 2% cream and 10% for those using placebo cream (p less than 0.0001). Ketoconazole-treated patients who were cured at the end of treatment remained cured 8 weeks later. By contrast 75% of those responding to placebo had relapsed by the 8-week follow-up visit. Follow-up after 2 years revealed that 79% (38/48) of the patients treated with ketoconazole remained clear 12 or more months. | lld:pubmed |
pubmed-article:3760275 | pubmed:language | eng | lld:pubmed |
pubmed-article:3760275 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3760275 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:3760275 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3760275 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:3760275 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:3760275 | pubmed:month | Sep | lld:pubmed |
pubmed-article:3760275 | pubmed:issn | 0190-9622 | lld:pubmed |
pubmed-article:3760275 | pubmed:author | pubmed-author:SavinR CRC | lld:pubmed |
pubmed-article:3760275 | pubmed:author | pubmed-author:HorwitzS NSN | lld:pubmed |
pubmed-article:3760275 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:3760275 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:3760275 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:3760275 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:3760275 | pubmed:pagination | 500-3 | lld:pubmed |
pubmed-article:3760275 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:meshHeading | pubmed-meshheading:3760275-... | lld:pubmed |
pubmed-article:3760275 | pubmed:year | 1986 | lld:pubmed |
pubmed-article:3760275 | pubmed:articleTitle | Double-blind comparison of 2% ketoconazole cream and placebo in the treatment of tinea versicolor. | lld:pubmed |
pubmed-article:3760275 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:3760275 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:3760275 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |